Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Guidi

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|July 3, 2025
Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysisBibie Said, Yuan Pétermann, Patrick Howlett, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysisDavid Haefliger, Lynn Mina, Monia Guidi, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2012
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and TanzaniaEva Maria Staehli Hodel, Chantal Csajka, Frédéric Ariey, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT studyFrédéric Gaspar, Jean Terrier, Samantha Favre, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2026
Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAF<sup>V600E/K</sup>-mutant metastatic melanomaYuan J Pétermann, Alicja Puszkiel, Abbas Khani, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulationKim Dao, Aline Fuchs, Pascal André, et al.
Clinical Pharmacokinetics|November 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMOStéphane Bertin, Monia Guidi, David Haefliger, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2019
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life settingCatalina Barcelo, Manel Aouri, Perrine Courlet, et al.
Pharmacology Research & Perspectives|January 29, 2020
Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteersKim Dao, Paul Thoueille, Laurent A Decosterd, et al.
Chemotherapy|November 7, 2024
Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic DrugsClaire Seydoux, Myriam Briki, Anna D Wagner, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|July 3, 2025
Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysisBibie Said, Yuan Pétermann, Patrick Howlett, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysisDavid Haefliger, Lynn Mina, Monia Guidi, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2012
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and TanzaniaEva Maria Staehli Hodel, Chantal Csajka, Frédéric Ariey, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT studyFrédéric Gaspar, Jean Terrier, Samantha Favre, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2026
Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAF<sup>V600E/K</sup>-mutant metastatic melanomaYuan J Pétermann, Alicja Puszkiel, Abbas Khani, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulationKim Dao, Aline Fuchs, Pascal André, et al.
Clinical Pharmacokinetics|November 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMOStéphane Bertin, Monia Guidi, David Haefliger, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2019
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life settingCatalina Barcelo, Manel Aouri, Perrine Courlet, et al.
Pharmacology Research & Perspectives|January 29, 2020
Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteersKim Dao, Paul Thoueille, Laurent A Decosterd, et al.
Chemotherapy|November 7, 2024
Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic DrugsClaire Seydoux, Myriam Briki, Anna D Wagner, et al.
Pageof 11